Provided by Tiger Trade Technology Pte. Ltd.

Carlisle

333.64
-6.2900-1.85%
Post-market: 333.640.00000.00%17:16 EDT
Volume:362.56K
Turnover:121.14M
Market Cap:13.64B
PE:19.49
High:341.47
Open:336.57
Low:330.78
Close:339.93
52wk High:435.92
52wk Low:293.43
Shares:40.88M
Float Shares:40.33M
Volume Ratio:0.72
T/O Rate:0.90%
Dividend:4.20
Dividend Rate:1.26%
EPS(TTM):17.12
EPS(LYR):17.12
ROE:34.87%
ROA:10.38%
PB:7.60
PE(LYR):19.49

Loading ...

CSL (CMXHF) Receives a Buy from Morgan Stanley

TIPRANKS
·
Jan 27

CSL (CMXHF) Gets a Buy from Citi

TIPRANKS
·
Jan 27

The Bull Case For Carlisle Companies (CSL) Could Change Following Its Vision 2030 Acquisition Drive – Learn Why

Simply Wall St.
·
Jan 26

How Investors May Respond To CSL (ASX:CSL) After RBC Upgrade Amid Seqirus Spin-Off Pause

Simply Wall St.
·
Jan 23

Shenzhen CSL Vacuum Science and Technology Prices IPO, Seeks Up to 1.56 Billion Yuan in Proceeds

MT Newswires Live
·
Jan 22

Assessing CSL (ASX:CSL) Valuation After RBC Capital Upgrade And Recent Share Price Selloff

Simply Wall St.
·
Jan 21

Carlisle Companies Inc. to Announce Fourth Quarter Results

Reuters
·
Jan 21

CSL upgraded to Outperform from Sector Perform at RBC Capital

TIPRANKS
·
Jan 19

A Look At Carlisle Companies (CSL) Valuation After Recent Share Price Strength Rebuilds Longer Term Momentum

Simply Wall St.
·
Jan 14

A Look At CSL (ASX:CSL) Valuation As Investors Await Plasma And Vaccine Update In February Results

Simply Wall St.
·
Jan 13

CSL Reports Lapse of 34,261 Conditional Rights Under Equity Plan

TIPRANKS
·
Jan 09

Shenzhen CSL Vacuum Science and Technology Launches Shanghai IPO

MT Newswires Live
·
Jan 08

Seqirus Spin-Off Pause and Plasma Push Could Be A Game Changer For CSL (ASX:CSL)

Simply Wall St.
·
Jan 07

CSL (ASX:CSL) Valuation Check After Outlook Cut And Cancelled Seqirus Spin Off

Simply Wall St.
·
Jan 06

Can Carlisle Companies Incorporated's (NYSE:CSL) ROE Continue To Surpass The Industry Average?

Simply Wall St.
·
Dec 26, 2025

CSL (ASX:CSL) Valuation Check After Robust Five-Year HEMGENIX Gene Therapy Results

Simply Wall St.
·
Dec 12, 2025

Did Five-Year HEMGENIX Data Just Shift CSL's (ASX:CSL) Gene Therapy Investment Narrative?

Simply Wall St.
·
Dec 11, 2025

CSL Finance Appoints Chief Business Officer; Shares Up 3%

MT Newswires Live
·
Dec 09, 2025

Shares of CSL Fall After Audit Office Statement on Unit's Vaccine Deal

MT Newswires Live
·
Dec 09, 2025

CSL Limited Updates on Ongoing Share Buy-Back

TIPRANKS
·
Nov 26, 2025